Related Experiment Video
Updated: Jun 21, 2026
08:33
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
Published on: April 25, 2014
Chromosomal changes in aggressive breast cancers with basal-like features.
Wayne Yu1, Yasmine Kanaan, Young Kyung Bae
1The Department of Oncology and the Sydney Kimmel Cancer Center, Johns Hopkins University School of Medicine, 1550 East Orleans Street, Baltimore, MD 21057, USA.
Cancer Genetics and Cytogenetics
|July 16, 2009
Summary
Genomic analysis of basal-like breast cancers reveals significant chromosomal copy number alterations. Despite heterogeneity, specific gene amplifications may offer targeted treatment opportunities.
Area of Science:
- Genomics
- Cancer Biology
- Oncology
Background:
- Basal-like breast cancers are a high-grade subtype with distinct molecular features.
- Understanding genomic alterations is crucial for classifying and treating breast cancer subtypes.
Purpose of the Study:
- To investigate chromosomal copy number changes in basal-like breast cancers.
- To identify potential genomic biomarkers or therapeutic targets within this subtype.
Main Methods:
- High-resolution oligonucleotide comparative genomic hybridization (CGH) arrays were used.
- 16 basal-like breast cancer samples were analyzed for copy number variations.
- Immunohistochemistry was employed to confirm gene expression in amplified regions.
Main Results:
- All 16 basal-like breast cancers exhibited numerous chromosomal gains and losses.
- Frequent losses were observed on 5q, 8p, 9q, 12q, 17p, 19p, and Xq.
- Common gains were noted on 1q, 8q, and 17q, with high-level amplifications in specific oncogenes (cKIT, JUND, AKT2).
Conclusions:
- Genomic alterations in basal-like breast cancers are highly heterogeneous.
- No single chromosomal alteration universally characterizes this subtype.
- Specific high-level amplifications present potential therapeutic targets for subsets of these cancers.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...